0001054074-23-000009.txt : 20230920 0001054074-23-000009.hdr.sgml : 20230920 20230920105506 ACCESSION NUMBER: 0001054074-23-000009 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230920 DATE AS OF CHANGE: 20230920 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc. CENTRAL INDEX KEY: 0001720893 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821386754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38410 FILM NUMBER: 231265603 BUSINESS ADDRESS: STREET 1: 555 LONG WHARF DRIVE CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-643-8060 MAIL ADDRESS: STREET 1: 555 LONG WHARF DRIVE CITY: NEW HAVEN STATE: CT ZIP: 06511 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 144 144 1 primary_doc.xml 144 0001256126 XXXXXXXX LIVE 0001720893 BioXcel Therapeutics, Inc. 001-38410 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060 MUELLER PETER Officer common Cowen and Company LLC

599 Lexington Ave, 27th floor new york NY 10022

96993 290979.00 29270000 09/20/2023 NASDAQ COMMON 06/21/2018 Restricted Stock Units BioXcel Therapeutics, Inc N 96993 06/21/2018 Company Compensation Y 09/20/2023 03/21/2023 /s/ Peter Mueller